An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition

FDA’s Review Of Peptides Signals A Growing Public Health Challenge

A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.